Ketamine Treatment & Integration

The Story Mental health in America is getting worse, not better. Traditional talk therapy helps many people, but others hit a wall—months or years of sessions without breaking through. That's where Daytryp comes in.

Daytryp is a therapy clinic offering something different: medically supervised psychedelic treatment that can compress six months of progress into one. Ketamine—an anesthetic used safely in hospitals since the 1970s—has psychedelic properties that open the heart, shift perspective, and help patients process trauma, addiction, anxiety, and depression in ways talk therapy alone can't reach.

The Approach This video follows Rudy Montijo, MS, LASAC, an integration therapist at Daytryp, as he walks through the full patient journey: intake assessment, medical screening, the ceremonial treatment session with a trained trip guide, and the critical integration work afterward. The goal was to demystify psychedelic therapy—showing the clinical rigor, the intentionality, and the human care behind every session.

Rather than sensationalizing the psychedelic angle, we focused on the process and the outcomes: a 17-year-old with suicidal ideation who found stability. A doctor carrying decades of resentment toward his father who finally found compassion. Real people finding relief when nothing else worked.

The Result An educational piece that positions Daytryp as both medically credible and deeply human—exactly what prospective patients and referring providers need to see before trusting a clinic with something this vulnerable.